264 related articles for article (PubMed ID: 32580068)
21. Prognostic value of microRNA-125a expression status in molecular groups of pediatric medulloblastoma.
Hamam SM; Abdelzaher E; Fadel SH; Nassra RA; Sharafeldin HA
Childs Nerv Syst; 2023 Jul; 39(7):1869-1880. PubMed ID: 36892621
[TBL] [Abstract][Full Text] [Related]
22. Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
Achiha T; Kijima N; Kodama Y; Kagawa N; Kinoshita M; Fujimoto Y; Nonaka M; Fukai J; Inoue A; Nishida N; Yamanaka T; Harada A; Mori K; Tsuyuguchi N; Uda T; Ishibashi K; Tomogane Y; Sakamoto D; Shofuda T; Yoshioka E; Kanematsu D; Mano M; Luu B; Taylor MD; Kanemura Y; Kishima H
PLoS One; 2020; 15(12):e0243272. PubMed ID: 33270750
[TBL] [Abstract][Full Text] [Related]
23. Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.
Mynarek M; Obrecht D; Sill M; Sturm D; Kloth-Stachnau K; Selt F; Ecker J; von Hoff K; Juhnke BO; Goschzik T; Pietsch T; Bockmayr M; Kool M; von Deimling A; Witt O; Schüller U; Benesch M; Gerber NU; Sahm F; Jones DTW; Korshunov A; Pfister SM; Rutkowski S; Milde T
Acta Neuropathol; 2023 Jan; 145(1):97-112. PubMed ID: 36459208
[TBL] [Abstract][Full Text] [Related]
24. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.
Martins-da-Silva A; Baroni M; Salomão KB; das Chagas PF; Bonfim-Silva R; Geron L; Cruzeiro GAV; da Silva WA; Corrêa CAP; Carlotti CG; de Paula Queiroz RG; Marie SKN; Brandalise SR; Yunes JA; Scrideli CA; Valera ET; Tone LG
Cell Mol Neurobiol; 2023 Mar; 43(2):813-826. PubMed ID: 35366170
[TBL] [Abstract][Full Text] [Related]
25. Molecular Classification of Medullobastomas by Whole Genome Expression Profiling.
Nosková H; Adamcová S; Knoflíčková LDR; Pavelka Z; Vejmělková K; Zitterbart K; Slabý O; Štěrba J
Klin Onkol; 2019; 32(Supplementum1):171-173. PubMed ID: 31064192
[TBL] [Abstract][Full Text] [Related]
26. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.
Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C
Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917
[No Abstract] [Full Text] [Related]
27. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
28. Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach.
Kaur K; Kakkar A; Kumar A; Mallick S; Julka PK; Gupta D; Suri A; Suri V; Sharma MC; Sarkar C
Brain Pathol; 2016 May; 26(3):334-43. PubMed ID: 26222673
[TBL] [Abstract][Full Text] [Related]
29. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
Remke M; Hielscher T; Korshunov A; Northcott PA; Bender S; Kool M; Westermann F; Benner A; Cin H; Ryzhova M; Sturm D; Witt H; Haag D; Toedt G; Wittmann A; Schöttler A; von Bueren AO; von Deimling A; Rutkowski S; Scheurlen W; Kulozik AE; Taylor MD; Lichter P; Pfister SM
J Clin Oncol; 2011 Oct; 29(29):3852-61. PubMed ID: 21911727
[TBL] [Abstract][Full Text] [Related]
30. Clinicomorphological and molecular analysis of medulloblastoma and association with survival: A single tertiary care center experience.
Badiger S; Gudipati A; Uppin M; Konatam ML; Yeramneni VK; Bhattacharjee S; Saradhi MV; Patnaik S; Irukulla M
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S592-S602. PubMed ID: 38384024
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
[TBL] [Abstract][Full Text] [Related]
32. PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.
Wang S; Zhang D; Wang J; Peng X; Sun H; Ji Y; Yang Z; Bian X; Hou Y; Ge M; Liu Y
J Neurooncol; 2024 May; 168(1):139-149. PubMed ID: 38662151
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of human Sonic Hedgehog (SHH) medulloblastoma stem-like cells.
Ronci M; Catanzaro G; Pieroni L; Po A; Besharat ZM; Greco V; Levi Mortera S; Screpanti I; Ferretti E; Urbani A
Mol Biosyst; 2015 Jun; 11(6):1603-11. PubMed ID: 25756958
[TBL] [Abstract][Full Text] [Related]
34. Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations.
Okonechnikov K; Schrimpf D; Koster J; Sievers P; Milde T; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M; Korshunov A
Acta Neuropathol; 2024 Jun; 147(1):95. PubMed ID: 38847845
[TBL] [Abstract][Full Text] [Related]
35. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.
Blüml S; Margol AS; Sposto R; Kennedy RJ; Robison NJ; Vali M; Hung LT; Muthugounder S; Finlay JL; Erdreich-Epstein A; Gilles FH; Judkins AR; Krieger MD; Dhall G; Nelson MD; Asgharzadeh S
Neuro Oncol; 2016 Jan; 18(1):126-31. PubMed ID: 26254476
[TBL] [Abstract][Full Text] [Related]
36. Wnt activation as a therapeutic strategy in medulloblastoma.
Manoranjan B; Venugopal C; Bakhshinyan D; Adile AA; Richards L; Kameda-Smith MM; Whitley O; Dvorkin-Gheva A; Subapanditha M; Savage N; Tatari N; McKenna D; Bassey-Archibong B; Winegarden N; Hallett R; Provias JP; Yarascavitch B; Ajani O; Fleming A; Bader GD; Pugh TJ; Doble BW; Singh SK
Nat Commun; 2020 Aug; 11(1):4323. PubMed ID: 32859895
[TBL] [Abstract][Full Text] [Related]
37. Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.
Łastowska M; Jurkiewicz E; Trubicka J; Daszkiewicz P; Drogosiewicz M; Malczyk K; Grajkowska W; Matyja E; Cukrowska B; Pronicki M; Perek-Polnik M; Perek D; Dembowska-Bagińska B
J Neurooncol; 2015 May; 123(1):65-73. PubMed ID: 25862008
[TBL] [Abstract][Full Text] [Related]
38. Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma.
Zhao F; Li C; Zhou Q; Qu P; Wang B; Wang X; Zhang S; Wang X; Zhao C; Zhang J; Luo L; Ai L; Xu L; Liu P
J Neurooncol; 2017 Nov; 135(2):353-360. PubMed ID: 28808827
[TBL] [Abstract][Full Text] [Related]
39. IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma.
Kunhiraman H; McSwain L; Shahab SW; Gershon TR; MacDonald TJ; Kenney AM
Acta Neuropathol Commun; 2023 Apr; 11(1):62. PubMed ID: 37029430
[TBL] [Abstract][Full Text] [Related]
40. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
